GOTHENBURG, Sweden, May 29, 2020 /PRNewswire/ -- Zlatko Rihter has been appointed President and CEO of the medical solutions company, Moelnlycke Health Care AB.
Zlatko Rihter is a Swedish citizen and currently President and CEO of Sweden-based CellaVision, a world-leading provider of digital solutions for medical microscopy in the field of hematology, listed on Nasdaq Nordic.
"We are very pleased to see Zlatko Rihter joining Moelnlycke. He brings solid knowledge from the medtech industry and a strong track record of growth based on innovation and customer focus," says Gunnar Brock, Chairman of Moelnlycke.
Zlatko Rither has extensive experience from the healthcare sector after having spent more than 20 years within the industry. Prior to joining CellaVision in 2015, Zlatko Rither held the position as EVP Sales & Marketing at ORIGIO, as well as President GBU Chronic at Gambro and Director Patient Handling Product Division at ArjoHuntleigh.
Zlatko Rihter's starting date as President and CEO of Moelnlycke is still to be confirmed.
"I am very honoured to join Moelnlycke, a company I have admired over the years. I believe that with my industry experience and various operational roles in different companies I can contribute to the success of Moelnlycke," says Zladko Rihter.
For more information, please contact:
Jenny Johansson
Global Manager
Corporate Communicatons
jenny.johansson@molnlycke.com
Phone: +46(0)739-41-29-23
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/molnlycke/r/zlatko-rihter-appointed-new-ceo-of-molnlycke,c3122898
The following files are available for download:
Release |
|
E4A1148 |
